AMG 595

Generic Name: AMG 595
Study IDStudied Indication or DiseasePhaseStudy TitleSynopsis
20090505Advanced Recurrent Malignant Glioma1aA Phase 1 First-in-human Study Evaluating Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 595 in Subjects With Recurrent Malignant Glioma Expressing Mutant Epidermal Growth Factor Receptor Variant III (EGFRvIII)